BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37134022)

  • 1. Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy.
    Matović J; Bahrami K; Stockmann P; Sokka IK; Khng YC; Sarparanta M; Hey-Hawkins E; Rautio J; Ekholm FS
    Mol Pharm; 2023 Jun; 20(6):3127-3139. PubMed ID: 37134022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diastereoselective Synthesis of the Borylated d-Galactose Monosaccharide 3-Boronic-3-Deoxy-d-Galactose and Biological Evaluation in Glycosidase Inhibition and in Cancer for Boron Neutron Capture Therapy (BNCT).
    Simone MI
    Molecules; 2023 May; 28(11):. PubMed ID: 37298796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
    Kawasaki R; Oshige A; Yamana K; Hirano H; Nishimura K; Miura Y; Yorioka R; Sanada Y; Bando K; Tabata A; Yasuhara K; Miyazaki Y; Shinoda W; Nishimura T; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Nagasaki T; Ikeda A
    Chemistry; 2023 Dec; 29(72):e202302486. PubMed ID: 37792507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and
    Matović J; Järvinen J; Sokka IK; Imlimthan S; Raitanen JE; Montaser A; Maaheimo H; Huttunen KM; Peräniemi S; Airaksinen AJ; Sarparanta M; Johansson MP; Rautio J; Ekholm FS
    Mol Pharm; 2021 Jan; 18(1):285-304. PubMed ID: 33390018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the Biochemical Foundations of a Glucose-Based "Trojan Horse"-Strategy to Boron Neutron Capture Therapy: From Chemical Synthesis to
    Matović J; Järvinen J; Bland HC; Sokka IK; Imlimthan S; Ferrando RM; Huttunen KM; Timonen J; Peräniemi S; Aitio O; Airaksinen AJ; Sarparanta M; Johansson MP; Rautio J; Ekholm FS
    Mol Pharm; 2020 Oct; 17(10):3885-3899. PubMed ID: 32787269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective.
    Nakamura H
    Future Med Chem; 2013 Apr; 5(6):715-30. PubMed ID: 23617433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
    Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
    Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.
    Kawasaki R; Hirano H; Yamana K; Isozaki H; Kawamura S; Sanada Y; Bando K; Tabata A; Yoshikawa K; Azuma H; Takata T; Tanaka H; Sakurai Y; Suzuki M; Tarutani N; Katagiri K; Sawada SI; Sasaki Y; Akiyoshi K; Nagasaki T; Ikeda A
    Nanomedicine; 2023 Apr; 49():102659. PubMed ID: 36822335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy.
    Yamana K; Kawasaki R; Sanada Y; Tabata A; Bando K; Yoshikawa K; Azuma H; Sakurai Y; Masunaga SI; Suzuki M; Sugikawa K; Nagasaki T; Ikeda A
    Biochem Biophys Res Commun; 2021 Jun; 559():210-216. PubMed ID: 33957482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
    Worm DJ; Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Med Chem; 2020 Mar; 63(5):2358-2371. PubMed ID: 31589041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
    Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
    Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-Selective Functionalization of Carboranes at the Electron-Rich Boron Vertex: Photocatalytic B-C Coupling via a Carboranyl Cage Radical.
    Chen M; Xu J; Zhao D; Sun F; Tian S; Tu D; Lu C; Yan H
    Angew Chem Int Ed Engl; 2022 Sep; 61(37):e202205672. PubMed ID: 35670361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
    Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards carborane-functionalised structures for the treatment of brain cancer.
    Calabrese G; Daou A; Barbu E; Tsibouklis J
    Drug Discov Today; 2018 Jan; 23(1):63-75. PubMed ID: 28886331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formulation of polyhedral boranes for the boron neutron capture therapy of cancer.
    Calabrese G; Nesnas JJ; Barbu E; Fatouros D; Tsibouklis J
    Drug Discov Today; 2012 Feb; 17(3-4):153-9. PubMed ID: 21978988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
    Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
    Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
    Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
    Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).
    Itoh T; Tamura K; Ueda H; Tanaka T; Sato K; Kuroda R; Aoki S
    Bioorg Med Chem; 2018 Dec; 26(22):5922-5933. PubMed ID: 30420329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.